US Patent Issued to Poseida Therapeutics on July 21 for "Anti-MUC1 compositions and methods of use" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,726, issued on July 21, was assigned to Poseida Therapeutics Inc. (San Diego).

"Anti-MUC1 compositions and methods of use" was invented by Eric M. Ostertag (San Diego) and Devon Shedlock (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are antibodies against MUC1, MUC1-CAR compositions and methods for use of these antibodies and compositions to target a MUC1 protein, wherein a cell expressing the MUC1 protein may be targeted and killed by, for instance, a cytotoxic T cell."

The patent was filed on Dec. 18, 2020, under Application No. 17/785,825.

*For further information, including images, charts and tables, please visit: http://...